Organization · Venture Capital
DNV Capital 德诺资本
DNV Capital is an international venture capital firm based in Shenzhen, China, focusing on investments in healthcare and innovative technology sectors. The firm engages in equity investment, mergers and acquisitions, and project financing.
Overview
What DNV Capital 德诺资本 does
What DNV Capital 德诺资本 is
DNV Capital is an international venture capital firm based in Shenzhen, China, focusing on investments in healthcare and innovative technology sectors. The firm engages in equity investment, mergers and acquisitions, and project financing.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2011
- Approximate age
- About 15 years
- Structured capabilities
- Funder
- Last reviewed
- April 9, 2026
Official channels
Find DNV Capital 德诺资本 elsewhere
Open the official website or a supported primary organization account.
Capability profile
DNV Capital 德诺资本 as a funder
Investment thesis
DNV Capital focuses on investing in high-quality enterprises in the healthcare and hard technology sectors, leveraging global resources and expertise to drive innovation and growth.
Focus narrative
DNV Capital invests primarily in the growth, expansion, and maturity stages of companies. Its investment focus includes the healthcare industry, covering areas such as chemical drugs, medical devices, biopharmaceuticals, precision medicine, AI healthcare, traditional Chinese medicine, and consumer healthcare. In addition, the firm invests in hard technology sectors, including artificial intelligence, aerospace, next-generation information technology, and new materials.
Value beyond capital
DNV Capital adds value to its portfolio companies through strategic guidance, access to industry expertise, and collaboration opportunities. The firm leverages its extensive network of industry experts and capital elites to support the growth and innovation of its investments.
Focus and fit
- Stages
- Growth Equity · Series A · Series B · Series C · Series D · Series E · Series F
- Regions
- Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 10
- Recorded notable exits
- Vessix
Portfolio context
Notable portfolio companies include: Vessix: Specializes in radiofrequency ablation technology for resistant hypertension, acquired by Boston Scientific. 品驰医疗 (Pinchi Medical): Develops neurostimulation products for conditions like Parkinson's disease and epilepsy. 海创药业 (Hinova Pharma): Focused on cancer and metabolic disease drug research with several products in clinical trials. 轩竹生物 (XuanZhu Bio): Invests heavily in innovative drug development. 世和基因 (GeneSeq): Specializes in personalized medicine and high-throughput sequencing technology. 华科精准 (HuaKe Precision): Develops intelligent surgical platforms for neurosurgery. 术锐机器人 (ShuRui Robotics): Focuses on minimally invasive surgical robots. 滨会生物 (BinHui Bio): Develops innovative cancer treatments using oncolytic viruses. 启明医疗 (Qiming Medical): Leader in minimally invasive heart valve interventions in China. Sorrento Therapeutics: Focuses on oncology and immunotherapy.
Common questions
What to know about DNV Capital 德诺资本
Upseed classifies DNV Capital 德诺资本 under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 9, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.